Targeted multifunctional multimodal protein-shell microspheres as cancer imaging contrast agents

Molecular Imaging and Biology

Volumn 14, Issue 1, 2012, Pages 17-24

  John, Renu ^a   Nguyen, Freddy T ^a   Kolbeck, Kenneth J ^a   Chaney, Eric J ^a   Marjanovic, Marina ^a   Suslick, Kenneth S ^a   Boppart, Stephen A ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b University of Illinois at Urbana Champaign   (United States)

Author keywords

Alpha(v) beta(3) targeting; Contrast agents; Iron oxide; Magnetic resonance imaging; Magnetomotive optical coherence tomography; Protein microspheres; RGD peptide; Ultrasound imaging

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; MICROSPHERE; NANOPARTICLE; OIL; PROTEIN SHELL MICROSPHERE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BIOACCUMULATION; BREAST FIBROADENOMA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; FLUORESCENCE MICROSCOPY; IMAGING SYSTEM; IN VIVO STUDY; MAGNETOMETRY; MOLECULAR IMAGING; NANOENCAPSULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; TUMOR MODEL;

ANIMALS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEASIBILITY STUDIES; FEMALE; INTEGRIN ALPHAVBETA3; MAGNETITE NANOPARTICLES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICROBUBBLES; MICROSPHERES; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84861478435     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0473-7     Document Type: Article

References (30)

1. Wang X, Yang L, Chen Z, Shin DM (2008) Application of nanotechnology to cancer therapy and imaging. CA Cancer J Clin 58:97-110 (Pubitemid 351521865)
2. Moghimi SM, Hunter AC, Murray JC (2005) Nanomedicine: current status and future prospects. FASEB J 19:311-330 (Pubitemid 40316520)
3. Boppart SA, Oldenburg AL, Xu C, Marks DL (2005) Optical probes and techniques for molecular contrast enhancement in coherence imaging. J Biomed Opt 10:041208
4. Lee TM, Toublan FJ, Sitafalwalla S et al (2003) Engineered microsphere contrast agents for optical coherence tomography. Opt Lett 28:1456-1458
5. McCarthy JR, Weissleder R (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug deliv Rev 60:1241-1251
6. Gao X, Gui Y, Levenson RM et al (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969-976 (Pubitemid 39014473)
7. Huang D, Swanson EA, Lin CP et al (1991) Optical coherence tomography. Science 254:1178-1181 (Pubitemid 21917444)
8. Bouma BE, Tearney GJ (eds) (2002) Handbook of Optical Coherence Tomography. Marcel Dekker, New York, New York
9. Boppart SA, Bouma BE, Pitris C et al (1998) Intraoperative assessment of microsurgery with three-dimensional optical coherence tomography. Radiology 208:81-86 (Pubitemid 28323313)
10. Nguyen FT, Zysk AM, Chaney EJ et al (2009) Intraoperative evaluation of breast tumor margins with optical coherence tomography. Cancer Res 69:8790-8796
11. Rao KD, Choma MA, Yazdanfar S et al (2003) Molecular contrast in optical coherence tomography by use of a pump-probe technique. Opt Lett 28:340-342
12. Xu C, Ye J, Marks DL, Boppart SA (2004) Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. Opt Lett 29:1647-1649
13. Oldenburg AL, Hansen MN, Zweifel DA et al (2006) Plasmon-resonant gold nanorods as low backscattering albedo contrast agents for optical coherence tomography. Opt Express 14:6724-6738 (Pubitemid 44118111)
14. Cang H, Sun T, Li Z-Y et al (2005) Gold nanocages as contrast agents for spectroscopic optical coherence tomography. Opt Lett 30:3048-3050 (Pubitemid 41655030)
15. Barton JK, Hoying JB, Sullivan CJ (2002) Use of microbubbles as an optical coherence tomography contrast agent. Acad Radiol 9:S52-S55 (Pubitemid 34441440)
16. Rapoport N, Gao Z, Kennedy A (2007) Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99:1095-1106 (Pubitemid 47241394)
17. Kolbeck KJ (1999) Biomedical applications of protein microspheres, PhD Dissertation in Chemistry. University of Illinois at Urbana-Champaign, Urbana
18. Dibbern EM (2005) Core shell microspheres for biomedical applications, PhD Dissertation, Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois
19. Toublan FJJ, Boppart SA, Suslick KS (2006) Tumor targeting by surface-modified protein microspheres. J Am Chem. Soc.128:3472-3473
20. Oldenburg AL, Toublan FJ, Suslick KS et al (2005) Magnetomotive contrast for in vivo optical coherence tomography. Opt Express 13:6597-6614 (Pubitemid 41230884)
21. Oldenburg AL, Gunther JR, Boppart SA (2005) Imaging magnetically labeled cells with magnetomotive optical coherence tomography. Opt Lett 30:747-749 (Pubitemid 40449066)
22. Oldenburg AL, Crecea V, Rinne SA, Boppart SA (2008) Phase-resolved magnetomotive OCT for imaging nanomolar concentrations of magnetic nanoparticles in tissues. Opt Express 16:11525-11539
23. John R, Chaney EJ, Boppart SA (2010) Dynamics of magnetic nanoparticle-based contrast agents in tissues tracked using magneto-motive optical coherence tomography. IEEE J Sel Top Quantum Electron 16:691-697
24. John R, Rezaeipoor R, Adie SG et al (2010) In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes. Proc Natl Acad Sci USA 107:8085-8090
25. Unger EC, McCreery TP, Sweitzer RH (1998) A novel ultrasound contrast agent with therapeutic properties. Acad Radiol 5:S247-S249
26. Unger EC, McCreery TP, Sweitzer RH et al (1998) Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 33:886-892 (Pubitemid 30247061)
27. Eliceiri BP, Cheresh DA (1999) The role of alpha v beta 3 integrins during angiogenesis. J Clin Invest 103:1227-1230
28. Hoshiga M, Alpers CE, Smith LL et al (1995) Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res 77:1129-1135
29. Pasqualini R, Koivunen E, Ruoslahti E (1997) α v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 15:542-546
30. Winter PM, Morawski AM, Caruthers SD et al (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v) beta(3)-integrin- targeted nanoparticles. Circulation 108:2270-2274 (Pubitemid 37363046)